Related Experiment Video
Updated: Apr 19, 2026

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
1.0K
Behind the Numbers: Cancer Survivor Recruitment by Demographics and Clinical Status.
Michelle Y Martin1, Wendy Demark-Wahnefried2,3, Iman Omairi4
1Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Cancer Medicine
|April 18, 2026
Summary
Recruiting diverse cancer survivors for clinical trials is complex. Tailored approaches are needed to improve participation across different demographic and clinical groups.
Area of Science:
- Oncology
- Clinical Trials
- Health Disparities
Background:
- Recruiting cancer survivors into research studies involves multiple sequential steps.
- These recruitment steps can present varying levels of difficulty for different survivor populations.
- Understanding these challenges is crucial for improving trial diversity.
Purpose of the Study:
- To examine how sociodemographic and clinical characteristics of cancer survivors relate to their progression through recruitment stages.
- To identify factors influencing participation in the Adapting MultiPLe behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health trial.
- To inform strategies for enhancing diversity in clinical trial recruitment.
Main Methods:
- A cohort of 23,270 cancer survivors from population-based and hospital registries were invited to the AMPLIFI trial.
- The study tracked progression through four recruitment steps: being reached, screened for eligibility, deemed eligible, and consented.
- Bivariate and logistic regression analyses were used to assess associations between survivor characteristics and recruitment outcomes.
Main Results:
- Recruitment success varied significantly by survivor characteristics at each step.
- Being female, older (65+), African American, and diagnosed <2 years prior were associated with higher reach and screening.
- African American survivors and those from disadvantaged areas were less likely to consent, highlighting participation barriers.
Conclusions:
- Survivor characteristics differentially impact progression through clinical trial recruitment steps.
- Opportunities exist to develop tailored recruitment strategies to enhance diversity.
- Addressing disparities in recruitment is essential for equitable clinical trial participation and generalizable findings.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
856
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
856
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Treatment Resistent Cancers
1.5K
1.5K
Cancer Prevention
3.1K
3.1K
Cancer Prevention
8.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
8.7K
Cancer
56.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
56.4K

